Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Practice of Molecular Radiotherapy

  • You have access
    Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
    Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
  • You have access
    Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
    Robert M. Sharkey and David M. Goldenberg
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;
  • You have access
    Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
    Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
  • You have access
    Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
    Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
  • You have access
    Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
    Richard L. Wahl
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 128S-140S;
  • You have access
    The Promise of Targeted α-Particle Therapy
    Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;
  • You have access
    Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
    Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
  • You have access
    Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
    Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
  • You have access
    A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy
    Steven M. Larson and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
  • You have access
    Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
    Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire